Evaluation of Psychological Distress in Patients Undergoing Cancer Treatment in an Oncology Department During the COVID-19 Pandemic
Received Date : 17 Nov 2021
Accepted Date : 24 Mar 2022
Available Online : 05 Apr 2022
Doi: 10.37047/jos.2021-87089 - Article's Language: EN
J Oncol Sci. 2022;8(1):20-6
This is an open access article under the CC BY-NC-ND license
Objective: Patients with cancer have an increased risk of severe coronavirus disease-2019 (COVID-19) because their immune systems are suppressed due to cancer treatments or cancer itself. Therefore, patients with cancer are prone to COVID-19 infection. In this study, we evaluated the anxiety of patients receiving cancer treatment in our oncology department during the COVID-19 pandemic. Material and Methods: This descriptive cross-sectional study consisted of 220 patients receiving cancer treatment in the medical oncology clinic of our hospital between 01 and 30 April 2020. Study data were obtained using a questionnaire consisting of 26 questions. The Hospital Anxiety and Depression Scale was used to determine the patients’ psychological distress. The scale results were compared with the results of Kruskal-Wallis, Mann-Whitney U, and chi-square tests. Results: We observed that 80 (36.4%) and 40 (18.2%) of the 220 patients studied had risks of depression and anxiety, respectively. In this study, 46.4% of the patients believed that their illness was being negatively affected by the COVID-19 pandemic, and 45.5% of the patients worried that their treatment would be interrupted during this period. Conclusion: Our results suggest that patients with cancer need more psychosocial support than do the general population during this pandemic period. These needs should be considered while planning oncological health services, and appropriate arrangements should be made.
  1. Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and cancer: a comprehensive review. Curr Oncol Rep. 2020;22(5):53. [Crossref]  [PubMed]  [PMC] 
  2. World Health Organization. Coronavirus Disease (COVID-19) Dashboard. Nov 15, 2021. Available from: [Link] 
  3. Curigliano G, Banerjee S, Cervantes A, et al; Panel members. Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol. 2020;31(10):1320-1335. [Crossref]  [PubMed]  [PMC] 
  4. Yeoh CB, Lee KJ, Rieth EF, et al. COVID-19 in the cancer patient. Anesth Analg. 2020;131(1):16-23. [Crossref]  [PubMed]  [PMC] 
  5. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-337. [Crossref]  [PubMed]  [PMC] 
  6. Wang C, Pan R, Wan X, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5):1729. [Crossref]  [PubMed]  [PMC] 
  7. Xiang YT, Yang Y, Li W, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7(3):228-229. [Crossref]  [PubMed]  [PMC] 
  8. Wang Z, Wang J, He J. Active and effective measures for the care of patients with cancer during the COVID-19 spread in China. JAMA Oncol. 2020;6(5):631-632. [Crossref]  [PubMed] 
  9. Yeşil Çınkır H, Elboğa G. The illness perception and its association with distress in cancer patients receiving chemotherapy. Turk J Oncol. 2020;35(1):1-7. [Crossref] 
  10. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370. [Crossref]  [PubMed] 
  11. Aydemir Ö, Güvenir T, Küey L, Kültür S. [Validity and reliability of Turkish version of Hospital Anxiety and Depression Scale]. Türk Psikiyatri Derg. 1997;8(4):280-287. [Link] 
  12. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA. 1983;249(6):751-757. [Crossref]  [PubMed] 
  13. Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ. 2005;330(7493):702. [Crossref]  [PubMed]  [PMC] 
  14. Prieto JM, Blanch J, Atala J, et al. Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. J Clin Oncol. 2002;20(7):1907-1917. [Crossref]  [PubMed] 
  15. Colleoni M, Mandala M, Peruzzotti G, Robertson C, Bredart A, Goldhirsch A. Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet. 2000;356(9238):1326-1327. [Crossref]  [PubMed] 
  16. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160-174. [Crossref]  [PubMed] 
  17. Wang Y, Duan Z, Ma Z, et al. Epidemiology of mental health problems among patients with cancer during COVID-19 pandemic. Transl Psychiatry. 2020;10(1):263. [Crossref]  [PubMed]  [PMC] 
  18. Andersen BL, DeRubeis RJ, Berman BS, et al; American Society of Clinical Oncology. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol. 2014;32(15):1605-1619. [Crossref]  [PubMed]  [PMC] 
  19. World Health Organization. Mental health and psychosocial considerations during the COVID-19 outbreak. Interim guidance. Available from: [Link]